| 摘要 |
<p>Method for examination of the liver of a human patient, comprising the following sequential steps: a) providing a contrast agent comprising a physiologically acceptable non-chelate manganese (II) compound, a physiologically acceptable amino acid and a vitamin D; b) administering the contrast agent orally or gastrically to the patient; and c) subjecting the patient to magnetic resonance imaging (MRI) of the liver about 1-6 hours after administration of the contrast agent. Contrast agent as above for use in examination of the liver of a human patient by administration to the patient about 1-6 hours before subjecting the patient to MRI. Use of a physiologically acceptable non-chelate manganese (II) compound, a physiologically acceptable amino acid and a vitamin D for the manufacture of a contrast agent for examination of the liver of a human patient by administration to the patient about 1-6 hours before subjecting the patient to MRI.</p> |
